News & Downloads
News
March 2012
InPheno has been selected as preferred service provider for a Drug Discovery Program of a Russian drug development company.
January 2012
InPheno announces the successful conclusion of a Drug Discovery project funded by the European Commission. The consortium from 3 countries had aimed at identifying novel nucleoside analogues active on multi-drug resistant HIV-1 strains. As a result several patents applications have been filed and one manuscript was published.
Posters
Posters presented at international conferences:
- "Profiling a Maturation Inhibitor"; CROI, Montreal 2009
- "Drug combination – Coreceptor antagonist"; ICAAC, San Francisco 2009
- "Gag-SP1 polymorphism: BVT"; IHDRW, Sitges 2008
- "High Throughput screen on Natural Products"; HIV Entry meeting, Boston, 2007
- "Phenotyping Signal Transduction"; AACR, Chicago 2006
- "Replicative Phenotyping system for HIV"; HIV-DART, Cancun 2006
Publications
- Screen for potent HIV Inhibitors from plants; J.Nat.Prod., 2012
PMID: 22148316 - Anti-HIV activity of thiated thymidine analogues; Antiviral Research, 2011
PMID: 21683097 - rPhenotyping of HIV and clinical value; J.Translational Medicine, 2011
PMID: 21255386 - 3TC monotherapy for unfit HIV; JAIDS, 2010
PMID: 19838125 - HIV Tropism as predictor for disease progression; AIDS, 2008
PMID: 18301059 - rPhenotyping to detect viral minorities in clinical specimens; HIV Medicine, 2008
PMID: 18218003 - New CXCR4 inhibitor concept; Bioorg.&Med.Chem., 2006
PMID: 17010618 - Protease polymorphisms and viral fitness; J.Clin.Virol, 2006
PMID: 16765636 - HIV Genotyping and Phenotyping in clinical Diagnostics; Eur.J.Clin.Microbiol.Inf.Dis., 2005
PMID: 16328557